highly significantp = 0.000
Among these analyses, we observed a highly significant association of overall survival with combined TP53 and KRAS genetic alterations ( p = 0.000, median survival: 4 vs. 13 months).
Among these analyses, we observed a highly significant association of overall survival with combined TP53 and KRAS genetic alterations ( p = 0.000, median survival: 4 vs. 13 months).
The presence of KRAS pathogenic variants showed a marginally significant association with TP53 pathogenic variants ( p = 0.090, OR: 2.357, 95% CI: 0.859–6.465).